Human Ventures
386 Park Ave S Fl 5, New York City, New York, 10016, United States
Overview
Human Ventures is a fund and partner in New York City. They possess their own perspective on evaluating companies due to their experience in building businesses themselves. Consequently, Human Ventures focuses on supporting founders who are establishing category-defining companies in the pre-seed and seed stages. In terms of their investment focus, they concentrate on the Human Needs Economy, which encompasses areas such as health and wellness, the future of work and finance, the attention economy, and human connection through experiences.
- Total investments
- 42
- Lead investments
- 5
- Investments · 12mo
- 6
- Active investors
- 8
Sector focus
- Financial Services
- Venture Capital
Investment portfolio
- Breakaway Music Festival
Participated · Series B · Mar 2026
Breakaway produces touring music festivals and has expanded from festivals in four markets at the time of its 2022 Series A to 14 markets today. Founded in 2013, the company operates with more than 60 employees and offices in Nashville, Charlotte, Los Angeles and New York City. Annual revenue grew from about $15 million in 2022 to nearly $70 million last year. Each of Breakaway’s music festivals costs roughly $3 million to produce. In addition to its festivals, the company runs a record label and a digital content arm and plans to use proceeds from the recent Series B to scale those divisions and expand its touring business. The Series B pushed the company to a nine-figure valuation.
- Salvo Health
Participated · Series A · Jan 2026
Salvo Health offers brick-and-mortar gastrointestinal (GI) clinics a continuous virtual care platform that connects patients with a specialized, gut-focused care team. Users gain direct, ongoing access to registered dietitians, behavioral-health professionals, and nurses, helping clinics save time, boost revenue, and improve outcomes. In 2025 the company reported 800% year-over-year growth in both patients and revenue and expanded enterprise agreements with GI doctors by more than 1,000%, reaching 801 signed GI partners. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, the company is now building an AI-driven product roadmap. The new funding will finance engineering expansion and nationwide hiring of additional clinical staff to meet rising demand. Salvo Health positions itself at the intersection of virtual specialty care and chronic condition management, with ambitions to scale its platform nationally.
- Formulary Financial
Participated · Seed · Jan 2026
Formulary Financial provides end-to-end fund administration—covering accounting, reporting, compliance, audit, capital activity, and investor communications—through a single AI-driven platform. By unifying internal and external data sources, the software creates an auditable “one source of truth” and delivers real-time reporting to both general partners and limited partners. Embedded AI automates repetitive reconciliation tasks, freeing accountants to focus on higher-value advisory work. Early clients and design partners already manage billions of dollars in assets under management, using the platform to reduce manual effort and accelerate reporting cycles. The company positions its technology as a replacement for error-prone spreadsheets and legacy systems that dominate the $23 trillion private-markets sector. Formulary was founded in 2025 and is headquartered in New York City. Backed by prominent venture investors, the firm emerged from stealth in January 2026 with fresh capital to expand product capabilities and client reach.
- Honeyjar
Led · Seed · Dec 2025
Honeyjar is building an AI co-pilot that unifies the end-to-end workflow of communications and public relations, from messaging and media research to list building, pitching, events, coverage tracking, sentiment analysis, and reporting. The platform embeds proprietary AI agents that leverage brand context, goals, and campaign history to act like a virtual teammate, handling repetitive tasks while letting professionals focus on strategy, storytelling, and relationship building. A secure, collaborative workspace serves as the operating system for modern comms, powered by integrated news, social, and events data. The company has opened an Early Access waitlist for agencies, in-house teams, and independent pros as it refines the product. Honeyjar targets the $15 billion communications and PR market, positioning itself as purpose-built AI rather than a generic productivity tool. The San-Francisco-based startup recently secured $2 million in pre-seed funding to accelerate product development and go-to-market efforts. No revenue, user, or other operating metrics were disclosed in the announcement.
- Goodword
Led · Seed · Nov 2025
Goodword is building an AI platform that serves as a copilot for professional networking, using large language models from OpenAI to surface timely reminders, facilitate introductions, and provide smart search across a user’s contacts. The service unifies data from LinkedIn, calendars, email, and soon note-taking apps, automatically organizing relationships and prompting follow-ups so users can focus on high-value connections. Its annual subscription is priced at roughly $200, with a free trial available and a monthly plan slated for future release. Launched in beta in October, the New York-based startup currently employs five full-time staffers and three contractors. Co-founders Caroline Dell and Chris Fischer, who joined forces in 2024, emphasize keeping “the human at the center” rather than fully automating networking. Recent seed financing will fund additional data integrations, offset large-language-model expenses, and expand the research and development team. Although still pre-revenue at scale, Goodword is targeting what it calls a $200 billion global opportunity among professionals overwhelmed by digital connections.